TARS : Insider Transactions for Tarsus Pharmaceuticals, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Tarsus Pharmaceuticals, Inc. (TARS)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

33,110,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Tarsus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Co.'s primary product candidate, TP-03, is an investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Co. is developing product candidates to address targeted diseases with unmet medical needs, which include TP-03 for the potential treatment of Meibomian Gland Disease, TP-04 for the potential treatment of rosacea, and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	1,000	10,506	28,906
Total Buy Value	$0	$18,960	$178,661	$475,267
Total People Bought	0	1	2	2
Total Buy Transactions	0	1	2	3
Total Shares Sold	28,810	103,773	277,520	1,365,143
Total Sell Value	$881,586	$2,318,498	$5,607,786	$9,074,655
Total People Sold	5	6	6	9
Total Sell Transactions	5	11	25	115
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 211

Page 7 of 9

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Vivo Capital Fund Ix, L.p.

10% Owner

– – •

2022-05-05

4

S

$12.25

$65,832

I/I

(5,374)

2,469,001

-

Vivo Capital Fund Ix, L.p.

10% Owner

– – •

2022-05-04

4

S

$12.67

$250,080

I/I

(19,738)

2,474,375

-

Vivo Capital Fund Ix, L.p.

10% Owner

– – •

2022-05-03

4

S

$13.25

$5,981,289

I/I

(451,418)

2,494,113

-

Vivo Capital Fund Ix, L.p.

10% Owner

– – •

2022-05-02

4

S

$15.19

$634,942

I/I

(41,800)

2,945,531

-

Azamian Bobak R.

President and CEO

• • –

2021-12-01

4

AS

$23.86

$144,167

I/I

(5,833)

1,204,106

-

Ackermann Michael

Director

– • –

2021-12-01

4

AS

$23.85

$143,934

D/D

(5,833)

1,204,016

-

Link William J Phd

Director

– • –

2021-11-11

4

A

$0.00

$0

I/I

4,348

4,348

-

Link William J Phd

Director

– • –

2021-11-11

4

AS

$0.00

$0

I/I

(250,000)

862,301

-

Chief Commercial Officer

• – –

2021-11-08

4

AS

$28.11

$53,100

D/D

(1,889)

50,203

-

Chief Commercial Officer

• – –

2021-11-05

4

AS

$28.11

$309

D/D

(11)

52,092

-

Chief Commercial Officer

• – –

2021-11-04

4

AS

$28.03

$2,803

D/D

(100)

52,103

-

Chief Commercial Officer

• – –

2021-11-02

4

AS

$26.75

$160,690

D/D

(6,000)

52,203

-

Ackermann Michael

Director

– • –

2021-11-01

4

AS

$27.76

$162,289

D/D

(5,833)

1,209,849

-

Azamian Bobak R.

President and CEO

• • –

2021-11-01

4

AS

$27.76

$162,284

I/I

(5,833)

1,209,939

-

Azamian Bobak R.

President and CEO

• • –

2021-10-12

4

AS

$25.49

$145,448

I/I

(5,531)

1,215,772

-

Ackermann Michael

Director

– • –

2021-10-12

4

AS

$25.56

$148,000

D/D

(5,633)

1,215,682

-

Ackermann Michael

Director

– • –

2021-10-08

4

AS

$25.03

$5,006

D/D

(200)

1,221,315

-

Azamian Bobak R.

President and CEO

• • –

2021-10-08

4

AS

$25.02

$7,555

I/I

(302)

1,221,303

-

Chief Commercial Officer

• – –

2021-09-10

4

S

$22.15

$57,435

D/D

(2,593)

58,203

-

Chief Commercial Officer

• – –

2021-09-10

4

OE

$0.45

$48,973

D/D

6,943

60,796

-

Ackermann Michael

Director

– • –

2021-09-01

4

AS

$25.24

$147,237

D/D

(5,833)

1,221,515

-

Azamian Bobak R.

President and CEO

• • –

2021-09-01

4

AS

$25.23

$147,301

I/I

(5,833)

1,221,605

-

Ackermann Michael

Director

– • –

2021-08-11

4

AS

$25.15

$15,619

D/D

(621)

1,227,348

-

Azamian Bobak R.

President and CEO

• • –

2021-08-11

4

AS

$25.07

$48,061

I/I

(1,917)

1,227,438

-

Azamian Bobak R.

President and CEO

• • –

2021-08-10

4

AS

$25.00

$2,575

I/I

(103)

1,229,355

-

211 Records found	1 2 3 4 5 6 7 8 9	Page 7 of 9

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.